The intricate role of CXCR4 in cancer
S Chatterjee, BB Azad, S Nimmagadda - Advances in cancer research, 2014 - Elsevier
Chemokines mediate numerous physiological and pathological processes related primarily
to cell homing and migration. The chemokine CXCL12, also known as stromal cell-derived …
to cell homing and migration. The chemokine CXCL12, also known as stromal cell-derived …
SOX9 stem‐cell factor: clinical and functional relevance in cancer
M Aguilar-Medina, M Avendaño-Félix… - Journal of …, 2019 - Wiley Online Library
Transcriptional and epigenetic embryonic programs can be reactivated in cancer cells. As
result, a specific subset of undifferentiated cells with stem‐cells properties emerges and …
result, a specific subset of undifferentiated cells with stem‐cells properties emerges and …
Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion
JC Larsimont, KK Youssef, A Sanchez-Danes… - Cell stem cell, 2015 - cell.com
Sox9 is a transcription factor expressed in most solid tumors. However, the molecular
mechanisms underlying Sox9 function during tumorigenesis remain unclear. Here, using a …
mechanisms underlying Sox9 function during tumorigenesis remain unclear. Here, using a …
SOX9: The master regulator of cell fate in breast cancer
S Jana, BM Krishna, J Singhal, D Horne… - Biochemical …, 2020 - Elsevier
SRY-related high-mobility group box 9 (SOX9) is an indispensable transcription factor that
regulates multiple developmental pathways related to stemness, differentiation, and …
regulates multiple developmental pathways related to stemness, differentiation, and …
New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy
L Zeng, Y Zhu, CS Moreno, Y Wan - Seminars in cancer biology, 2023 - Elsevier
Despite the development of cancer therapies, the success of most treatments has been
impeded by drug resistance. The crucial role of tumor cell plasticity has emerged recently in …
impeded by drug resistance. The crucial role of tumor cell plasticity has emerged recently in …
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties
EV Abel, M Goto, B Magnuson, S Abraham… - Elife, 2018 - elifesciences.org
The biological properties of pancreatic cancer stem cells (PCSCs) remain incompletely
defined and the central regulators are unknown. By bioinformatic analysis of a human PCSC …
defined and the central regulators are unknown. By bioinformatic analysis of a human PCSC …
Exosome circCMTM3 promotes angiogenesis and tumorigenesis of hepatocellular carcinoma through miR‐3619‐5p/SOX9
K Hu, NF Li, JR Li, ZG Chen, JH Wang… - Hepatology …, 2021 - Wiley Online Library
Aim As one of the most common and lethal carcinomas, hepatocellular carcinoma (HCC) is
a global health concern and affects millions of people worldwide. Current treatments for …
a global health concern and affects millions of people worldwide. Current treatments for …
HIF-3α promotes metastatic phenotypes in pancreatic cancer by transcriptional regulation of the RhoC–ROCK1 signaling pathway
X Zhou, X Guo, M Chen, C Xie, J Jiang - Molecular Cancer Research, 2018 - AACR
Hypoxia contributes to pancreatic cancer progression and promotes its growth and invasion.
Previous research principally focused on hypoxia-inducible factor-1 alpha (HIF-1α) and HIF …
Previous research principally focused on hypoxia-inducible factor-1 alpha (HIF-1α) and HIF …
[HTML][HTML] SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
Z Wang, X Xu, N Liu, Y Cheng, W Jin, P Zhang… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor with limited
therapeutic options. Glioma stem cell (GSC) is thought to be greatly responsible for glioma …
therapeutic options. Glioma stem cell (GSC) is thought to be greatly responsible for glioma …
Antiproliferative and apoptotic effects of telmisartan in human glioma cells
Glioblastoma is the most common primary central nervous system tumor in adults.
Angiotensin II receptor blockers (ARBs) are broadly applied to treat hypertension. Moreover …
Angiotensin II receptor blockers (ARBs) are broadly applied to treat hypertension. Moreover …